ARQ531: the therapy that targets multiple pathways in acute myeloid leukemia

Lignende værker

• Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents
  af: Antonia Cagnetta, et al.
  Udgivet: (2018-01-01)
• Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment
  af: Debora Soncini, et al.
  Udgivet: (2021-10-01)
• Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation.
  af: Terence G Hall, et al.
  Udgivet: (2016-01-01)
• CO32 | ARQ531 targets MAPK–S6K1 signaling and synergizes with lenalidomide in RAS-mutant and wild-type multiple myeloma
  af: Debora Soncini
  Udgivet: (2026-03-01)
• ARQ531: the therapy that targets multiple pathways in acute myeloid leukemia
  af: Charlotte Hellmich, et al.
  Udgivet: (2020-10-01)